Literature DB >> 11055555

Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells.

N A Syed1, R L Khandelwal.   

Abstract

The effect of insulin on glycogen synthesis and key enzymes of glycogen metabolism, glycogen phosphorylase and glycogen synthase, was studied in HepG2 cells. Insulin stimulated glycogen synthesis 1.83-3.30 fold depending on insulin concentration in the medium. Insulin caused a maximum of 65% decrease in glycogen phosphorylase 'a' and 110% increase in glycogen synthase activities in 5 min. Although significant changes in enzyme activities were observed with as low as 0.5 nM insulin level, the maximum effects were observed with 100 nM insulin. There was a significant inverse correlation between activities of glycogen phosphorylase 'a' and glycogen synthase 'a' (R2= 0.66, p < 0.001). Addition of 30 mM glucose caused a decrease in phosphorylase 'a' activity in the absence of insulin and this effect was additive with insulin up to 10 nM concentration. The inactivation of phosphorylase 'a' by insulin was prevented by wortmannin and rapamycin but not by PD98059. The activation of glycogen synthase by insulin was prevented by wortmannin but not by PD98059 or rapamycin. In fact, PD98059 slightly stimulated glycogen synthase activation by insulin. Under these experimental conditions, insulin decreased glycogen synthase kinase-3beta activity by 30-50% and activated more than 4-fold particulate protein phosphatase- activity and 1.9-fold protein kinase B activity; changes in all of these enzyme activities were abolished by wortmannin. The inactivation of GSK-3beta and activation of PKB by insulin were associated with their phosphorylation and this was also reversed by wortmannin. The addition of protein phosphatase-1 inhibitors, okadaic acid and calyculin A, completely abolished the effects of insulin on both enzymes. These data suggest that stimulation of glycogen synthase by insulin in HepG2 cells is mediated through the PI-3 kinase pathway by activating PKB and PP-1G and inactivating GSK-3beta. On the other hand, inactivation of phosphorylase by insulin is mediated through the PI-3 kinase pathway involving a rapamycin-sensitive p70(s6k) and PP-1G. These experiments demonstrate that insulin regulates glycogen phosphorylase and glycogen synthase through (i) a common signaling pathway at least up to PI-3 kinase and bifurcates downstream and (ii) that PP-1 activity is essential for the effect of insulin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11055555     DOI: 10.1023/a:1007159422667

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  53 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 2.  Regulation of glycogen synthase activation in isolated hepatocytes.

Authors:  S Pugazhenthi; R L Khandelwal
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

Review 3.  The structure and regulation of protein phosphatases.

Authors:  P Cohen
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

4.  The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf.

Authors:  D A Cross; D R Alessi; J R Vandenheede; H E McDowell; H S Hundal; P Cohen
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

5.  Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin.

Authors:  D F Lazar; R J Wiese; M J Brady; C C Mastick; S B Waters; K Yamauchi; J E Pessin; P Cuatrecasas; A R Saltiel
Journal:  J Biol Chem       Date:  1995-09-01       Impact factor: 5.157

6.  Insulin alters the sensitivity of glycogen synthesis to inhibition by okadaic acid, a protein phosphatase inhibitor.

Authors:  M Peak; L Aguis
Journal:  Biochem Pharmacol       Date:  1992-06-09       Impact factor: 5.858

7.  Insulin and glucose suppress hepatic glycogenolysis by distinct enzymatic mechanisms.

Authors:  Z Liu; L B Gardner; E J Barrett
Journal:  Metabolism       Date:  1993-12       Impact factor: 8.694

8.  Insulin regulation of skeletal muscle glycogen metabolism.

Authors:  J L Chiasson; M R Dietz; H Shikama; M Wootten; J H Exton
Journal:  Am J Physiol       Date:  1980-07

9.  Regulation of both glycogen synthase and PHAS-I by insulin in rat skeletal muscle involves mitogen-activated protein kinase-independent and rapamycin-sensitive pathways.

Authors:  I Azpiazu; A R Saltiel; A A DePaoli-Roach; J C Lawrence
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

10.  Ras-independent and wortmannin-sensitive activation of glycogen synthase by insulin in Chinese hamster ovary cells.

Authors:  H Sakaue; K Hara; T Noguchi; T Matozaki; K Kotani; W Ogawa; K Yonezawa; M D Waterfield; M Kasuga
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

View more
  12 in total

Review 1.  Emerging Roles of Vascular Endothelium in Metabolic Homeostasis.

Authors:  Xinchun Pi; Liang Xie; Cam Patterson
Journal:  Circ Res       Date:  2018-08-03       Impact factor: 17.367

2.  IRS2 mutations linked to invasion in pleomorphic invasive lobular carcinoma.

Authors:  Sha Zhu; B Marie Ward; Jun Yu; Asia N Matthew-Onabanjo; Jenny Janusis; Chung-Cheng Hsieh; Keith Tomaszewicz; Lloyd Hutchinson; Lihua Julie Zhu; Dina Kandil; Leslie M Shaw
Journal:  JCI Insight       Date:  2018-04-19

Review 3.  Regulation of hepatic glucose metabolism in health and disease.

Authors:  Max C Petersen; Daniel F Vatner; Gerald I Shulman
Journal:  Nat Rev Endocrinol       Date:  2017-07-21       Impact factor: 43.330

Review 4.  Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation.

Authors:  Amedeo Lonardo; Alessandro Mantovani; Salvatore Petta; Amedeo Carraro; Christopher D Byrne; Giovanni Targher
Journal:  Nat Rev Endocrinol       Date:  2022-07-15       Impact factor: 47.564

5.  Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

Authors:  Olwyn Johnston; Caren L Rose; Angela C Webster; John S Gill
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

Review 6.  mTOR inhibitors and renal allograft: Yin and Yang.

Authors:  Gianluigi Zaza; Simona Granata; Paola Tomei; Valentina Masola; Giovanni Gambaro; Antonio Lupo
Journal:  J Nephrol       Date:  2014-05-08       Impact factor: 3.902

7.  Impaired PI3 K Akt expression in liver and skeletal muscle of ovariectomized rats.

Authors:  Yan Wang; Baoxin Li; Wei Zhang; Yan Liu; Peng Xue; Jianxia Ma; Yukun Li
Journal:  Endocrine       Date:  2013-02-02       Impact factor: 3.633

8.  Regulation of Adipose Tissue Metabolism in Humans: Analysis of Responses to the Hyperinsulinemic-Euglycemic Clamp Experiment.

Authors:  Jaeyeon Kim; Gerald M Saidel; Satish C Kalhan
Journal:  Cell Mol Bioeng       Date:  2011-06-01       Impact factor: 2.321

9.  Subcellular localization of hexokinases I and II directs the metabolic fate of glucose.

Authors:  Scott John; James N Weiss; Bernard Ribalet
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

10.  Mild electrical stimulation with heat shock ameliorates insulin resistance via enhanced insulin signaling.

Authors:  Saori Morino; Tatsuya Kondo; Kazunari Sasaki; Hironori Adachi; Mary Ann Suico; Erika Sekimoto; Tomoko Matsuda; Tsuyoshi Shuto; Eiichi Araki; Hirofumi Kai
Journal:  PLoS One       Date:  2008-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.